NCT03198013View on ClinicalTrials.gov

A Study of Pharmacokinetics (PK) and Pharmacodynamics (PD) in Relation to Prednisolone in Healthy Males

PHASE1CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 11, 2008

Primary Completion Date

May 18, 2009

Study Completion Date

May 18, 2009

Conditions
Immunoscience
Interventions
DRUG

Prednisolone

Specified dose on specified days

DRUG

BMS-791826

Specified dose on specified days

DRUG

Placebo

Specified dose on specified days

Trial Locations (1)

3004

Local Institution, Melbourne

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY